World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
101
Citations
58821
World Ranking
7804
National Ranking
262

Overview

Luigi Bolondi is affiliated with the University of Bologna in Italy and focuses their research primarily in the field of Medicine. Their work has a particular emphasis on Hepatology, with additional contributions to Pathology and Forensic Medicine, Critical Care and Intensive Care Medicine, Pulmonary and Respiratory Medicine, and Radiology, Nuclear Medicine and Imaging.

The main topics covered in their research include:

  • Hepatocellular Carcinoma Treatment and Prognosis
  • Cancer Mechanisms and Therapy
  • Liver Physiology and Pathology
  • Ultrasound in Clinical Applications
  • Phonocardiography and Auscultation Techniques
  • Ultrasound Imaging and Elastography
  • Liver Disease and Transplantation

Luigi Bolondi has contributed to publications in several scientific venues. These include:

  • ESMO Open
  • Medical Ultrasonography
  • Journal of Nephrology
  • Hepatoma Research

Recent papers authored or co-authored by Luigi Bolondi include:

  • Second-line cabozantinib after sorafenib treatment for advanced hepatocellular carcinoma: a subgroup analysis of the phase 3 CELESTIAL trial, 2020, ESMO Open
  • History of Ultrasound in Medicine from its birth to date (2022), on occasion of the 50 Years Anniversary of EFSUMB. A publication of the European Federation of Societies for Ultrasound In Medicine and Biology (EFSUMB), designed to record the historical development of medical ultrasound, 2022, Medical Ultrasonography
  • Detoxification of bilirubin and bile acids with intermittent coupled plasmafiltration and adsorption in liver failure (HERCOLE study), 2020, Journal of Nephrology
  • BOOST: a phase 3 trial of sorafenib vs. best supportive care in first line treatment of hepatocellular carcinoma in patients with deteriorated liver function, 2021, Hepatoma Research

Some of the frequent co-authors contributing to Luigi Bolondi's research include:

  • Fabio Piscaglia
  • RobinKate Kelley
  • Baek-Yeol Ryoo
  • Philippe Merle
  • Joong-Won Park

Best Publications

  • Sorafenib in Advanced Hepatocellular Carcinoma

    Josep M. Llovet;Sergio Ricci;Vincenzo Mazzaferro;Philip Hilgard

  • Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma

    Ghassan K. Abou-Alfa;Tim Meyer;Ann Lii Cheng;Anthony B. El-Khoueiry

  • Hepatocellular Carcinoma and Cirrhosis in 746 Patients: Long-Term Results of Percutaneous Ethanol Injection

    T Livraghi;A Giorgio;G Marin;A Salmi

  • Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - Update 2008

    M. Claudon;D. Cosgrove;T. Albrecht;L. Bolondi

  • Cyclin G1 Is a Target of miR-122a, a MicroRNA Frequently Down-regulated in Human Hepatocellular Carcinoma

    Laura Gramantieri;Manuela Ferracin;Francesca Fornari;Angelo Veronese

  • Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial

    Jordi Bruix;Tadatoshi Takayama;Vincenzo Mazzaferro;Gar Yang Chau

  • Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals

    Fabio Conti;Federica Buonfiglioli;Alessandra Scuteri;Cristina Crespi

  • Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial.

    Jordi Bruix;Jean Luc Raoul;Morris Sherman;Vincenzo Mazzaferro

  • Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis

    L Bolondi;S Sofia;S Siringo;S Gaiani

  • MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma.

    Francesca Fornari;Laura Gramantieri;Manuela Ferracin;A Veronese

  • Guidelines for the Use of Contrast Agents in Ultrasound - January 2004

    T Albrecht;M Blomley;L Bolondi;M Claudon

  • Heterogeneity of patients with intermediate (BCLC B) Hepatocellular Carcinoma: proposal for a subclassification to facilitate treatment decisions.

    Luigi Bolondi;Andrew Burroughs;Jean François Dufour;Peterr R. Galle

  • The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations.

    Fabio Piscaglia;Luigi Bolondi

  • Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization

    J.-L. Raoul;B. Sangro;A. Forner;V. Mazzaferro

  • Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma

    R Golfieri;E Giampalma;M Renzulli;R Cioni

  • Percutaneous Ethanol Injection in the Treatment of Hepatocellular Carcinoma in Cirrhosis. A Study on 207 Patients

    Tito Livraghi;Luigi Bolondi;Sergio Lazzaroni;Giuseppe Marin

  • Measurement of Gastric Emptying Time by Real-Time Ultrasonography

    Luigi Bolondi;Mauro Bortolotti;Vittorio Santi;Tiziana Calletti

  • Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival.

    Luigi Barbara;Giovanna Benzi;Stefano Gaiani;Fabio Fusconi

  • Characterization of small nodules in cirrhosis by assessment of vascularity: The problem of hypovascular hepatocellular carcinoma

    Luigi Bolondi;Stefano Gaiani;Natascia Celli;Rita Golfieri

  • MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells.

    Francesca Fornari;Laura Gramantieri;Catia Giovannini;Angelo Veronese

Frequent Co-Authors

Fabio Piscaglia
Fabio Piscaglia University of Bologna
Luigi Barbara
Luigi Barbara University of Bologna
Massimo Negrini
Massimo Negrini University of Ferrara
Antonio Daniele Pinna
Antonio Daniele Pinna University of Bologna
Gian Luca Grazi
Gian Luca Grazi University of Bologna
Marco Valgimigli
Marco Valgimigli University of Bern
Carlo M. Croce
Carlo M. Croce The Ohio State University
Mauro Bernardi
Mauro Bernardi University of Bologna
Massimo Colombo
Massimo Colombo Humanitas University
Marco Zoli
Marco Zoli University of Bologna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

While earning a medical degree traditionally requires in-person study and clinical work, there are many online degree options in related healthcare fields that support flexible learning and career advancement. For those interested in patient wellness and preventative care, online degrees in nutrition can lead to meaningful roles in hospitals, clinics, or community health.

Advancing into healthcare management is also possible through cahme-accredited online mha programs, which prepare graduates for administrative and leadership positions in medical organizations. Current nurses can further their education and job prospects by enrolling in online rn to bsn programs no clinicals, designed for working professionals seeking to build upon their RN credentials without additional in-person clinical requirements.

For those aiming for the highest levels of nursing practice, short dnp programs online offer accelerated pathways to a Doctor of Nursing Practice degree—often with flexible schedules for busy professionals. Exploring these online options can help you tailor your education to match your career goals in the evolving healthcare landscape.

Best Scientists Citing Luigi Bolondi

Trending Scientists

Recently Published Articles